5 Next-Generation Psychedelics Entering Clinical Trials This Year
Modernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.
clearmind medicine
Psychedelic Business Spotlight – May 20
This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.
Drinking to Excess? Psychedelics Can Help
Clearmind Medicine CEO Adi Zuloff-Shani writes this guest blog about how a new psychoactive molecule called MEAI can treat alcoholism.
Psychedelic Business Spotlight: November 26
This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big money; Cybin makes psychedelic therapy more accessible in NYC.
Psychedelic Business Spotlight: October 15
This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new psilocybin license; and FDA backs ketamine.
End of content
End of content